Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (9): 790-793.DOI: 10.3969/j.issn.1673-8640.2018.09.004

Previous Articles     Next Articles

Changes of serum thyroid peroxidase antibody and thyroglobulin antibody in patients with hyperthyroidism heart disease

WANG Yao   

  1. Department of Ultrasound,Sanya People's Hospital,Sanya 572000,Hainan,China
  • Received:2017-12-25 Online:2018-09-30 Published:2018-10-13

Abstract:

Objective To investigate the changes of serum thyroid peroxidase antibody(TPOAb) and thyroglobulin antibody(TgAb) in patients with hyperthyroidism heart disease(HHD). Methods A total of 100 patients with HHD and 100 patients with hyperthyroidism were enrolled,and their general data [sex,age,body mass index(BMI),hyperthyroidism course and mean arterial pressure(MAP)] were collected. Serum TPOAb and TgAb levels were determined. Results There was no statistical significance for sex,age,BMI,hyperthyroidism course and MAP between HHD and hyperthyroidism groups (P>0.05). Serum TPOAb and TgAb levels in HHD group were higher than those in hyperthyroidism group before and after treatment(P<0.001). In HHD group,serum TPOAb and TgAb after treatment were lower than those before treatment(P<0.001). There were 76 effective cases (76.00%) and 24 invalid cases(24.00%)in HHD group. After treatment,serum TPOAb and TgAb levels in effective cases were lower than those before treatment and in invalid cases(P<0.001). For invalid cases,serum TPOAb and TgAb levels had no statistical significance before and after treatment (P>0.05). Serum TPOAb and TgAb levels in effective cases after treatment had no statistical significance compared with hyperthyroidism group (P>0.05). Conclusions Serum TPOAb and TgAb levels may be related to the occurrence and transfer of HHD,and they can be used as reference indices for evaluating curative effects.

Key words: Thyroid peroxidase antibody, Thyroglobulin antibody, Hyperthyroidism heart disease

CLC Number: